Pfizer's (PFE.US) $43 billion Seagen (SGEN.US) deal wins unconditional EU approval. As it was concluded by European lawmakers, deal wouldn't raise competition concerns or higher prices for oncology drugs.
Source: xStation5
MIDDAY WRAP: Mixed sentiment in Europe, declines on U.S. indices
Wells Fargo: Q4 was disappointing, but the forecasts for 2026 spark the imagination 💡🏛️
Saab shares surge as Scandinavian rearmament drives demand 📈
Will the U.S. Supreme Court decision shake Wall Street? 🗽 These stocks could benefit